144 related articles for article (PubMed ID: 12926088)
1. Expression of HER-2/neu in testicular tumors.
Mandoky L; Geczi L; Bodrogi I; Toth J; Bak M
Anticancer Res; 2003; 23(4):3447-51. PubMed ID: 12926088
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of HER-2/neu expression in germ-cell testicular tumors.
Mándoky L; Géczi L; Bodrogi I; Tóth J; Csuka O; Kásler M; Bak M
Anticancer Res; 2004; 24(4):2219-24. PubMed ID: 15330164
[TBL] [Abstract][Full Text] [Related]
3. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor expression and activation in nonseminomatous germ cell tumors.
Moroni M; Veronese S; Schiavo R; Carminati O; Sorensen BS; Gambacorta M; Siena S
Clin Cancer Res; 2001 Sep; 7(9):2770-5. PubMed ID: 11555591
[TBL] [Abstract][Full Text] [Related]
5. Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patients.
Shackney SE; Pollice AA; Smith CA; Janocko LE; Sweeney L; Brown KA; Singh SG; Gu L; Yakulis R; Lucke JF
Clin Cancer Res; 1998 Apr; 4(4):913-28. PubMed ID: 9563885
[TBL] [Abstract][Full Text] [Related]
6. Identification and relationship of HER-2/neu overexpression to short-term mortality in primary malignant brain tumors.
Forseen SE; Potti A; Koka V; Koch M; Fraiman G; Levitt R
Anticancer Res; 2002; 22(3):1599-602. PubMed ID: 12168843
[TBL] [Abstract][Full Text] [Related]
7. Germ-cell tumors of the mediastinum.
Weidner N
Semin Diagn Pathol; 1999 Feb; 16(1):42-50. PubMed ID: 10355653
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic value of the lung resistance-related protein (LRP) in germ cell testicular tumors.
Mándoky L; Géczi L; Doleschall Z; Bodrogi I; Csuka O; Kásler M; Bak M
Anticancer Res; 2004; 24(2C):1097-104. PubMed ID: 15154630
[TBL] [Abstract][Full Text] [Related]
9. Absence of c-KIT and members of the epidermal growth factor receptor family in refractory germ cell cancer.
Kollmannsberger C; Mayer F; Pressler H; Koch S; Kanz L; Oosterhuis JW; Looijenga LH; Bokemeyer C
Cancer; 2002 Jul; 95(2):301-8. PubMed ID: 12124830
[TBL] [Abstract][Full Text] [Related]
10. Her-2/neu expression and amplification in early stage ovarian surface epithelial neoplasms.
Wu Y; Soslow RA; Marshall DS; Leitao M; Chen B
Gynecol Oncol; 2004 Dec; 95(3):570-5. PubMed ID: 15581965
[TBL] [Abstract][Full Text] [Related]
11. Proteomics of breast cancer: enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors.
Zhang DH; Tai LK; Wong LL; Sethi SK; Koay ES
Proteomics; 2005 May; 5(7):1797-805. PubMed ID: 15825149
[TBL] [Abstract][Full Text] [Related]
12. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor-beta expression in human testicular germ cell tumors.
Pais V; Leav I; Lau KM; Jiang Z; Ho SM
Clin Cancer Res; 2003 Oct; 9(12):4475-82. PubMed ID: 14555521
[TBL] [Abstract][Full Text] [Related]
14. Primary germ cell tumors of the mediastinum: I. Analysis of 322 cases with special emphasis on teratomatous lesions and a proposal for histopathologic classification and clinical staging.
Moran CA; Suster S
Cancer; 1997 Aug; 80(4):681-90. PubMed ID: 9264351
[TBL] [Abstract][Full Text] [Related]
15. The prognostic and predictive value of immunohistochemically detected HER-2/neu overexpression in 361 patients with ovarian cancer: a multicenter study.
Riener EK; Arnold N; Kommoss F; Lauinger S; Pfisterer J
Gynecol Oncol; 2004 Oct; 95(1):89-94. PubMed ID: 15385115
[TBL] [Abstract][Full Text] [Related]
16. Loss of Fhit expression in testicular germ cell tumors and intratubular germ cell neoplasia.
Eyzaguirre E; Gatalica Z
Mod Pathol; 2002 Oct; 15(10):1068-72. PubMed ID: 12379753
[TBL] [Abstract][Full Text] [Related]
17. Alpha-fetoprotein in germ cell tumors. An immunohistochemical study.
Chaudhary RK; Kher A; Bobhate SK; Grover S
Indian J Pathol Microbiol; 1989 Jul; 32(3):167-73. PubMed ID: 2476392
[TBL] [Abstract][Full Text] [Related]
18. HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer.
Osman I; Scher HI; Drobnjak M; Verbel D; Morris M; Agus D; Ross JS; Cordon-Cardo C
Clin Cancer Res; 2001 Sep; 7(9):2643-7. PubMed ID: 11555574
[TBL] [Abstract][Full Text] [Related]
19. Ploidy of primary germ cell tumors of the testis. Pathogenetic and clinical relevance.
Oosterhuis JW; Castedo SM; de Jong B; Cornelisse CJ; Dam A; Sleijfer DT; Schraffordt Koops H
Lab Invest; 1989 Jan; 60(1):14-21. PubMed ID: 2536126
[TBL] [Abstract][Full Text] [Related]
20. [Importance of determination of various histologic components in testicular germ cell tumors].
Kruslin B; Turcić M; Cupić H; Novosel I; Reljić A; Ruzić B; Belicza M
Lijec Vjesn; 2003; 125(9-10):242-5. PubMed ID: 15038213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
